News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
We found that 5-aminolevulinic acid (5-ALA) and intraoperative MRI (iMRI) offer similar surgical outcomes in glioblastoma resection, with no superiority of iMRI
Photo from queensquare.com
Jun 25, 2023, 17:23

We found that 5-aminolevulinic acid (5-ALA) and intraoperative MRI (iMRI) offer similar surgical outcomes in glioblastoma resection, with no superiority of iMRI

In a post by

I am incredibly proud of our devoted and brilliant team. Their tireless efforts in pursuing the highest standards of care and their commitment to improving patient outcomes are unparalleled.
Our findings emphasize the importance of precision, efficiency, and cost-effectiveness in neurosurgery, which could guide future practice.
Our work reaffirms the value of relentless scientific inquiry in our pursuit to battle glioblastoma.”

Journal of Clinical Oncology – Click here

 

Source:

5-aminolevulinic acid cancer glioblastoma intra operative mri Neuro-Oncology neurosurgery OncoDaily Oncology Sotirios Bisdas unmethylated
Special Coverage
Blog
Nov 1, 2024, 20:27
Amy Oxentenko: Honored to be inducted as President of the American College of Gastroenterology
Blog
Nov 1, 2024, 20:22
Yan Leyfman: Honored to present our research at the 2024 Lymphoma, Leukemia and Myeloma Congress
Blog
Nov 1, 2024, 20:05
The Official Programme for Advancing Paediatric Oncology on Children’s Rights Day is Out - SIOP Europe
Blog
Nov 1, 2024, 19:20
Chandler Park: Dr. Petros Grivas answers the most important question for junior faculty
Blog
Nov 1, 2024, 19:12
ESTRO: Toxicity Profile of Immune Therapy Combined with Radiotherapy
Insight
Nov 1, 2024, 17:59
Ajay Major: Collect long-term follow-up data in survivors of Hodgkin lymphoma with the MyHodgkin MyHealth app
Blog
Nov 1, 2024, 17:52
Habib Nehmé: Strengthening Presence in Saudi Arabia’s Radiotherapy and Oncology Market
Blog
Nov 1, 2024, 17:46
Hidehito Horinouchi: Early Stage NSCLC at ACLC24 session
Blog
Nov 1, 2024, 17:41
Yelak Biru's interview with News 9 about the work IMF does
Insight
Nov 1, 2024, 17:31
Francisco Esteva: ADCs are making waves in the fight against advanced HER2+ breast cancer
Blog
Nov 1, 2024, 17:27
Alcohol consumption increases the risk of cancer at 7 sites - IARC
Blog
Nov 1, 2024, 17:17
Raul Cordoba: Valemetostat for relapsed or refractory peripheral T-cell lymphoma